Imperial Brands: small wins in these annual results
With tobacco volumes on the decline, this industry giant is chasing alternatives that could secure its future. ii's head of markets runs through these full-year numbers.
17th November 2026 08:27
by Richard Hunter from interactive investor

The opposing forces which have defined the tobacco sector for some considerable time remain in evidence, with Imperial Brands (LSE:IMB) shuffling the pack to reflect a changing environment.
- Our Services: SIPP Account | Stocks & Shares ISA | See all Investment Accounts
Changing lifestyle habits and high excise markets such as the UK and Australia have led to an ongoing decline in volumes. However, the ace up the sleeve for tobacco companies is that this remains a product which has inelastic demand, providing the ability to raise prices without unduly dampening demand. This pricing mix has seen the benefit as a result, with falling volumes more than offset by robust pricing.
Indeed, revenue for the year ended 30 September increased by 1.7% comprising a rise of 5.1% in pricing which more than offset the 3.4% decline in volumes.
Quite apart from the shifting landscape and the burden of regulatory censure which has plagued the sector over recent years, such as the planned UK government phased banning of combustible sales, there is also a reluctance among some investors to invest in tobacco companies at all on ethical grounds. As such, the tobacco companies have been racing towards Next Generation Products (NGP) as an alternative, and are doing so from a relatively recent standing start.
However, even after some years of investment which is currently incorporating higher marketing spend, Imperial's NGP unit is still loss-making as it reported an adjusted operating loss of £63 million for the period.
There are at least some signs of progress given a £5 million improvement from the previous year, while net revenue for the full year grew by 13.8% to £419 million, ahead of the expected £412 million. Double digit revenue growth is also anticipated for this year as a whole, which may help this part of the business continue to edge towards profitability, while the recent bolt-on complementary acquisitions in the US and Sweden are already having a beneficial impact.
- eyeQ: investors are buying the Nvidia dip. Should you?
- Stockwatch: my view on five share tips as interest rates rise
For the group as a whole, a detailed trading update in October removed any immediate surprises. In line with its own expectations, Imperial saw revenue decline by 1.5% to £31.68 billion, with growth of 3.7% in adjusted operating profit to £4.13 billion, slightly ahead of market estimates.
The expected acceleration came through in the second half as expected, although the reported figures were slightly lower given the impact of a £150 million Delaware settlement and 2030 strategy costs. Nonetheless, the group highlights the fact that the figure represents the sixth consecutive year of growth in net revenues and adjusted operating profit.
Elsewhere, the tobacco majors continue to benefit from the extraordinary cash generation which their sector enables, as evidenced by free cash flow of £2.6 billion which exceeded the group’s own £2.2 billion projection. Cost savings of £320 million are planned out to 2030 and, as such, the group retains its ability to choose between shareholder returns, investment in the business, paying down debt or indeed all of these.
- L&G Q3 results: are there better opportunities elsewhere?
- Week Ahead: British Land, Imperial Brands, JD Sports, Sage
At the present time, shareholder returns are in sharp focus, with the current £1.5 billion share buyback programme and a projected dividend yield of 5.6% adding to total returns for shareholders.
Imperial has maintained its guidance for the year to come, expecting a similar result to this year. Low single digit growth in tobacco net revenue and double digit growth in NGP is expected to repeat, with at least £2.2 billion of free cash flow. The group remains mindful of the Middle East impact on consumer behaviour while for the first half of the year to come there will be an impact due to a disruption in its supply chain in Ukraine, after an attack on its facilities there.
- Fund ideas for the ‘anti-AI’ investor
- Sign up to our free newsletter for investment ideas, latest news and award-winning analysis
Changing lifestyle habits and tougher regulation perennially overhang this sector, but in the meantime Imperial Brands continues to play the cards it has been dealt carefully. The shares are inevitably volatile given this landscape, as evidenced by a fall of 6% over the last year, as compared to a gain of 12% for the wider FTSE100, although the price remains ahead by 61% over the last three years.
Ethical issues aside, there are enough supporters of prospects for this group in an especially defensive sector to result in a market consensus of the shares as a buy.
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.